Antibacterial (Nano)medicines Development

Project Information

AND

Grant agreement ID: 659121

DOI 10.3030/659121

Project closed

EC signature date 18 March 2015

Start date 1 April 2015

End date 31 March 2017

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 165 598,80

EU contribution € 165 598,80

Coordinated by

WAGENINGEN UNIVERSITY
Netherlands

Publications

Peer reviewed articles (4)

Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of ε-poly-L-lysine capped mesoporous silica-based nanoparticles

Author(s): Nadya Velikova, Nuria Mas, Laura Miguel-Romero, Lorena Polo Aguado, Ellen Stolte, Edoardo Zaccaria, Rui Cao, Nico Taverne, José Ramón Murguía, Ramon Martinez-Manez, Alberto Marina, Jerry Wells
Published in: Nanomedicine: Nanotechnology, Biology and Medicine, 2016, ISSN 1549-9634
Publisher: Elsevier BV
DOI: 10.1016/j.nano.2016.09.011

Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis

Author(s): Nadya Velikova, Kevin Kavanagh, Jerry M. Wells
Published in: BMC Microbiology, Issue 16/1, 2016, ISSN 1471-2180
Publisher: BioMed Central
DOI: 10.1186/s12866-016-0905-2

Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients

Author(s): Nadya Velikova, Jerry Wellsa
Published in: Current Drug Targets, Issue 17/999, 2016, Page(s) 1-1, ISSN 1389-4501
Publisher: Bentham Science Publishers
DOI: 10.2174/1389450117666160208145934#sthash.jhGLdkL8.dpuf

Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens

Author(s): Nadya Velikova, Simone Fulle, Ana Sousa Manso, Milena Mechkarska, Paul Finn, J. Michael Conlon, Marco Rinaldo Oggioni, Jerry M. Wells, Alberto Marina
Published in: Scientific Reports, Issue 6, 2016, Page(s) 26085, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/srep26085